News for March 2017

News Archive

Services to Pharmaceutical Industry Prove Winning Formula for A4P Services to Pharmaceutical Industry Prove Winning Formula for A4P

When the bat phone rings at the Discovery Park offices of A4P it usually means there’s another challenge – with this talented team of scientists and logistics experts ready to leap into action and contribute wherever that may be.

NPL bolsters cancer research capabilities to unlock better patient outcomes NPL bolsters cancer research capabilities to unlock better patient outcomes

New projects will lead to improved diagnosis, reduced side effects of existing treatments, and the development of new, more effective ones

The Current issue of “The view from here” is concerned with Cancer and the search for Stem Cell donors for Stephen Sykes. The Current issue of “The view from here” is concerned with Cancer and the search for Stem Cell donors for Stephen Sykes.

The topic of this month’s newsletter from Drug Discovery Today is “Cancer”.

Scottish Universities Collaborate to Accelerate Drug Discovery Using Stem Cell Technology Scottish Universities Collaborate to Accelerate Drug Discovery Using Stem Cell Technology

Research teams based at the Universities of Dundee and Edinburgh are looking to partner with the pharmaceutical industry to better understand the biological processes that could allow the development of new drugs to support tissue regeneration or repair.

Cambridge Cognition launches web-based testing using digital cognitive markers for virtual research Cambridge Cognition launches web-based testing using digital cognitive markers for virtual research

The neuroscience digital health company Cambridge Cognition Holdings PLC, which develops and markets software products to improve brain health worldwide, today announced the launch of a new web-based testing product for conducting academic and clinical research studies online. Disorders affecting the brain are now the leading cause of disability and ill health worldwide. More than 1,000 disorders of the brain and central nervous system (CNS) result in huge costs and more hospitalisations and lost productivity than any other disease group, including heart disease and cancer.